Table 3.
Variables | Univariable analysis | Multivariable analysis | ||||
---|---|---|---|---|---|---|
Odds ratio (95% C.I.) | Std. Err. | P > |z| | Odds ratio (95% C.I.) | Std. Err. | P > |z| | |
Age (years) | 1.077 (1.063–1.091) | 0.007 | <0.001 | 1.092 (1.072–1.113) | 0.011 | <0.001 |
Suspicious DRE | 3.143 (2.467–4.005) | 0.388 | <0.001 | 2.701 (2.069–3.527) | 0.368 | <0.001 |
PSA (ng/mL) | 1.120 (1.093–1.147) | 0.014 | <0.001 | 1.155 (1.112–1.201) | 0.023 | <0.001 |
PVol (mL) | 0.969 (0.964–0.974) | 0.002 | <0.001 | 0.970 (0.964–0.977) | 0.003 | <0.001 |
PVR (mL) | 0.992 (0.990–0.995) | 0.001 | <0.001 | 0.994 (0.990–0.998) | 0.002 | 0.006 |
PFR (mL/s) | 1.021 (1.007–1.035) | 0.007 | 0.002 | 1.003 (0.983–1.024) | 0.010 | 0.752 |
DRE, digital rectal examination; ISUP, International Society of Urological Pathology; PCa, prostate cancer; PFR, peak flow rate; PSA, prostate-specific antigen; PVol, prostate volume; PVR, post-void residual urinary volume. The bold values are the statistically significant differences.